IP Library Granted Patent US 9,260,709
Granted Patent B2
US 9,260,709 · App. 13/516,545 · Granted Feb 16, 2016

Valencene synthase from callitropsis nootkatensis

Inventors: Jihane Achkar (Zurich, CH); Theodorus Sonke (Guttecoven, NL); Martinus Julius Beekwilder (Renkum, NL); Hendrik Jan Bouwmeester (Wageningen, NL); Hendrik Jan Bosch (Wageningen, NL)
Assignee: ISOBIONICS B.V.
C12N9/88C12P5/007C12P7/26C12P7/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,260,709
App. No.
13/516,545
Granted
Feb 16, 2016
Kind
B2
Abstract

The present invention relates to a valencene synthase, to a nucleic acid encoding such valencene synthase, to a host cell comprising said encoding nucleic acid sequence and to a method for preparing valencene, comprising converting farnesyl diphosphate to valencene in the presence of a valencene synthase according to the invention.

Claims (10)

1. A nucleic acid comprising a nucleic acid sequence encoding a valencene synthase having at least 95% sequence identity to the amino acid sequence set forth in SEQ ID NO:2, wherein the nucleic acid sequence has at least 95% sequence identity to the nucleic acid sequence set forth in SEQ ID NO:19.

2. An expression vector comprising the nucleic acid according to claim 1 .

3. A host cell, which may be an organism per se or part of a multi-cellular organism, said host cell comprising an expression vector according to claim 2 , which host cell is selected from the group consisting of bacterial cells, fungal cells and plant cells.

4. The host cell according to claim 3 , wherein the host cell is a bacterial cell selected from the group of gram negative bacteria.

5. A method for preparing valencene, said method comprising converting a farnesyl diphosphate to valencene in the presence of a valencene synthase comprising the amino acid sequence having at least 95% sequence identity to the amino acid sequence set forth in SEQ ID NO:2.

6. The method according to claim 5 , wherein the valencene is prepared in a host cell, a plant or plant culture or a mushroom or mushroom culture expressing said valencene synthase.

7. A method for preparing nootkatone, wherein valencene prepared in the method according to claim 5 is converted into nootkatone, which conversion may comprise a regiospecific hydroxylation of valencene followed by oxidation thereby forming nootkatone.

8. The method according to claim 7 , wherein the nootkatone is prepared in a host cell expressing at least one enzyme catalysing a reaction step for the conversion of valencene to nootkatone.

9. The host cell according to claim 4 , wherein the host cell is a bacterial cell selected from the group consisting of Rhodobacter, Paracoccus and Escherichia.

10. The host cell according to claim 9 , wherein the host cell is a bacterial cell selected from the group consisting of Rhodobacter capsulatus, Rhodobacter sphaeroides, Paracoccus carotinifaciens, Paracoccus zeaxanthinifaciens and Escherichia coli .

Assignments (2)
MERGER Recorded Sep 6, 2023
From: ISOBIONICS B.V.
To: BASF NEDERLAND B.V.
Reel/Frame 064819/0161 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2012
From: ACHKAR, JIHANE; SONKE, THEODORUS; BEEKWILDER, MARTINUS JULIUS; BOUWMEESTER, HENDRIK JAN; BOSCH, HENDRIK JAN
To: ISOBIONICS B.V.
Reel/Frame 029511/0891 →
Priority Claims (1)
EP 09179499 · Dec 16, 2009 · regional
Continuity (1)
Related Publication 20140075600A1 · Mar 13, 2014